Medical Treatments

The true health of politicians has likely been cloaked in secrecy since the days of Mesopotamian kings, but definitely since the Wilson administration. Has the time come to test presidents' cognition?

Skin lesions are often misdiagnosed as a brown recluse spider bite when they're actually a tick bite or MRSA or even skin cancer. Here's how to tell the difference.

CRISPR technology is already worth billions of dollars, investors say. This ruling seems to affirm the biggest piece of the pie goes to the Broad, over patent rival University of California, Berkeley.

Doctors treating people addicted to opioids often need approval from insurers before giving drugs that ease withdrawal. The delay can be risky for patients. Insurers are starting to come around.

Cooling caps haven't been studied much in the U.S., and only one is approved by the FDA. Studies of two different caps show they can reduce hair loss by half in many women undergoing chemo.

Many Duchenne muscular dystrophy patients in the U.S. have imported a medicine called deflazacort for about $1,200 a year. A brand-name version just approved for sale in America costs $89,000.

Senators unanimously voted to confirm VA Health Undersecretary Dr. David Shulkin as full secretary of the Department of Veterans Affairs. He's a rare Trump holdover from the Obama administration.

Citing a Kaiser Health News investigation, Sen. Chuck Grassley, chairman of the Senate Judiciary Committee, will examine potential abuses of incentives to spur development of drugs for rare diseases.

In 2014, the government said health providers would have to register with Medicare in order to prescribe drugs to beneficiaries. Delays have pushed back the requirement until 2019.